van Giezen, J J <br/><br/>
Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.  [electronic resource] 

 -  Thrombosis and haemostasis  Apr 1993 
 - 381-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Coagulation--drug effects<br/>Dose-Response Relationship, Drug<br/>Fibrinolysis--drug effects<br/>Fibrinolytic Agents--pharmacology<br/>Male<br/>Plasminogen Activator Inhibitor 1--analysis<br/>Plasminogen Activators--analysis<br/>Platelet Aggregation<br/>Rats<br/>Rats, Wistar<br/>Thrombophlebitis--prevention & control<br/>Tissue Plasminogen Activator--metabolism<br/>Tretinoin--pharmacology<br/>alpha-2-Antiplasmin--analysis